Securing the Unsecured: A Mayo Clinic Study on Propofol Disposal and Diversion Mitigation

Propofol is one of the most vulnerable medications for diversion in healthcare — not because it lacks abuse potential, but because it lacks the regulatory oversight applied to controlled substances.

In this episode of Rxpert Solutions, I’m joined by Michael T. Ring and Dale M. Pfrimmer to discuss their Mayo Clinic quality-improvement study published in Critical Care Nurse:

“Propofol as a Drug of Diversion: Changing Disposal Practices to Reduce Risk.”

Their work uncovered a major safety gap: before intervention, 44.1% of propofol bottles found in ICU waste bins were still full and accessible for diversion. After implementing activated carbon disposal pouches and specialized bottle-opening tools, that number dropped to zero.

We explore:
- The methodology behind their intervention
- Overcoming education and workflow challenges
- How environmental stewardship intersects with diversion prevention
- Why their success led to system-wide adoption across all ICUs and the ED

This episode highlights how simple, practical changes can meaningfully reduce diversion risk and protect healthcare professionals — even for medications outside DEA scheduling.

More from Rxpert Solutions: https://www.rxpert.solutions/?utm_source=spotify&utm_medium=insights&utm_campaign=mike-ring